Stock listing
NASDAQ:RPTX Repare Therapeutics Inc Stock
Follow Repare Therapeutics Inc into a list and get an email when it puts out news.
Last close · NASDAQ:RPTX
$2.65 USD
Close on Jan 27, 2026 · No longer trades
- Lowest – highest close
- $0.90 – $44.46 USDSince Jun 19, 2020 · lowest Apr 10, 2025 · highest Jan 7, 2021
Delisted NASDAQ:RPTX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:RPTX
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Repare Therapeutics Inc on 6ix
- Decks
- 4 decks · latest Dec 12, 2024
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Technical Presentation (December 2024) | Technical | 47 slides | Dec 12, 2024 |
| Investor Presentation (May 2024) | Investor deck | 47 slides | May 7, 2024 |
| Investor Presentation (October 2023) | Investor deck | 33 slides | Oct 13, 2023 |
| Technical Presentation (October 2023) | Technical | 47 slides | Oct 13, 2023 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Briggs Morrison Other companies: CRISPR Therapeutics AG (Director · Since at least Jun 5, 2025); Werewolf Therapeutics, Inc. (Director · Since at least Apr 29, 2021); Arvinas, Inc. (Chair of the Arvinas Board of Directors · Since at least Sep 26, 2018); Carisma Therapeutics, Inc. (Director · Mar 7, 2023 – Jun 26, 2024 · Past); Codiak BioSciences Inc (Director · Oct 13, 2020 – Feb 17, 2021 · Past); Oncorus Inc (Director · Oct 1, 2020 – Oct 1, 2020 · Past); NextCure, Inc. (Director · May 8, 2019 – Jun 11, 2020 · Past); Syndax Pharmaceuticals, Inc. (Director · Mar 2, 2016 – Feb 7, 2024 · Past) | Director · Jun 18, 2020 – Jun 17, 2024 · Past |
| Carol A. Schafer Other companies: Immunome, Inc. (Director · Since at least Jan 2, 2024); Kura Oncology, Inc. (Director · Since at least Jun 3, 2021); Insmed Incorporated (Director · Since at least May 12, 2021); Five Prime Therapeutics Inc (Director · Apr 16, 2021 – Apr 16, 2021 · Past); Aceragen Inc. (Director · Oct 1, 2020 – Jun 23, 2022 · Past) | Director · Since at least May 13, 2021 |
| Samarth Kulkarni Other companies: Oruka Therapeutics, Inc. (Director · Since at least Aug 29, 2024); Centessa Pharmaceuticals PLC (Director · Since at least May 27, 2021); Black Diamond Therapeutics, Inc. (CEO, CRISPR Therapeutics AG · Since at least Jan 29, 2020); CRISPR Therapeutics AG (Chief Executive Officer and Chairman of the Board · Since at least Oct 18, 2016) | Director · Jun 18, 2020 – Jun 17, 2024 · Past |
| Davis Jerel Other companies: Turnstone Biologics Corp. (Director · Since at least Jul 20, 2023); LENZ Therapeutics, Inc. (Director · Feb 16, 2021 – Jul 19, 2023 · Past); Aduro Biotech Inc (Director · Oct 5, 2020 – Aug 11, 2023 · Past) | Director · Jun 18, 2020 – Dec 29, 2022 · Past |
| Maria Koehler Other companies: ImageneBio, Inc. (Director · Apr 15, 2021 – Jun 7, 2024 · Past); ARS Pharmaceuticals, Inc. (Director · Mar 12, 2021 – Jun 10, 2022 · Past) | EVP, CHIEF MEDICAL OFFICER · Jun 18, 2020 – Mar 12, 2025 · Past |
| Lloyd M. Segal Other companies: Aktis Oncology, Inc. (INDEPENDENT DIRECTOR · Since at least Jan 8, 2026) | PRESIDENT AND CEO, Director · Jun 18, 2020 – Mar 12, 2025 · Past |
| Thomas Civik Other companies: Pyxis Oncology, Inc. (Chief Executive Officer and Chairman of the Board · Since at least Mar 26, 2024) | Director · Since at least Jun 17, 2024 |
| Michael Zinda | EVP, CHIEF SCIENTIFIC OFFICER · Dec 16, 2020 – Mar 12, 2025 · Past |
| Sandra Isabelle Barros Alves | SVP, Finance and CAO · Since at least Mar 31, 2025 |
| Steve Forte | EVP, CHIEF FINANCIAL OFFICER · Since at least Mar 1, 2024 |
Log in to ask 6ix AI your own questions about Repare Therapeutics Inc.